Company / Accounts Receivable
Eloxx Pharmaceuticals, Inc. Accounts Receivable History
FY2014-FY2014 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$43.1K
FY2014
5-year range
$43.1K / $43.1K
FY2014-FY2014
Trend
-
vs FY2013
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$43,133 in FY2014.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | $43.1K | - |
As of FY2014 · SEC 10-K · Updated Jun 24, 2026